Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (141-150 of 548) with videos related to

Pageof 55
Sort By:
Journal of Assisted Reproduction and Genetics|July 6, 2018
Fertility preservation in women with cancer: a national study about French oncologists awareness, experience, and feelingsAmira Sallem, Joanna Shore, Isabelle Ray-Coquard, et al.
Cancer|October 26, 2006
Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary sitePascal Seve, Isabelle Ray-Coquard, Veronique Trillet-Lenoir, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 31, 2023
The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinomaIsabelle Ray-Coquard, Bradley J Monk, Domenica Lorusso, et al.
Future Oncology (London, England)|August 31, 2023
NIRVANA-1: maintenance therapy with niraparib versus niraparib-bevacizumab in patients with advanced ovarian cancerSyrine Sghaier, Pauline Corbaux, Isabelle Ray-Coquard, et al.
BMC Cancer|October 27, 2015
KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcomeMehdi Brahmi, Laurent Alberti, Armelle Dufresne, et al.
Gynecologic Oncology|March 22, 2003
Epirubicin and paclitaxel (EPI-TAX regimen) for advanced ovarian cancer after failure of platinum-containing regimensIsabelle Ray-Coquard, Thomas Bachelot, Jean-Paul Guastalla, et al.
Cancer|October 27, 2004
CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancerChristophe Borg, Isabelle Ray-Coquard, Irene Philip, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 14, 2025
Is total mesorectal excision mandatory in advanced ovarian cancer patients undergoing posterior pelvic exenteration? Prognostic role of mesorectal space involvement in a prospective ovarian cancer cohortDomenico Ferraioli, Luca Fuso, Francesca Chiadó, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2011
Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: the AnemOnHe studyMarc Spielmann, Elisabeth Luporsi, Isabelle Ray-Coquard, et al.
Histopathology|September 29, 2023
Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovariiSophie Neyrand, Alexis Trecourt, Jonathan Lopez, et al.
Pageof 55

Showing results (141-150 of 548) with videos related to

Sort By:
Pageof 55
Journal of Assisted Reproduction and Genetics|July 6, 2018
Fertility preservation in women with cancer: a national study about French oncologists awareness, experience, and feelingsAmira Sallem, Joanna Shore, Isabelle Ray-Coquard, et al.
Cancer|October 26, 2006
Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary sitePascal Seve, Isabelle Ray-Coquard, Veronique Trillet-Lenoir, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 31, 2023
The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinomaIsabelle Ray-Coquard, Bradley J Monk, Domenica Lorusso, et al.
Future Oncology (London, England)|August 31, 2023
NIRVANA-1: maintenance therapy with niraparib versus niraparib-bevacizumab in patients with advanced ovarian cancerSyrine Sghaier, Pauline Corbaux, Isabelle Ray-Coquard, et al.
BMC Cancer|October 27, 2015
KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcomeMehdi Brahmi, Laurent Alberti, Armelle Dufresne, et al.
Gynecologic Oncology|March 22, 2003
Epirubicin and paclitaxel (EPI-TAX regimen) for advanced ovarian cancer after failure of platinum-containing regimensIsabelle Ray-Coquard, Thomas Bachelot, Jean-Paul Guastalla, et al.
Cancer|October 27, 2004
CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancerChristophe Borg, Isabelle Ray-Coquard, Irene Philip, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 14, 2025
Is total mesorectal excision mandatory in advanced ovarian cancer patients undergoing posterior pelvic exenteration? Prognostic role of mesorectal space involvement in a prospective ovarian cancer cohortDomenico Ferraioli, Luca Fuso, Francesca Chiadó, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2011
Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: the AnemOnHe studyMarc Spielmann, Elisabeth Luporsi, Isabelle Ray-Coquard, et al.
Histopathology|September 29, 2023
Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovariiSophie Neyrand, Alexis Trecourt, Jonathan Lopez, et al.
Pageof 55